NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
This Quarter Return
+5.77%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$797M
AUM Growth
+$797M
Cap. Flow
+$127M
Cap. Flow %
15.98%
Top 10 Hldgs %
92.1%
Holding
17
New
3
Increased
5
Reduced
1
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INGN icon
1
Inogen
INGN
$216M
$436M 54.68% 3,549,320
XLRN
2
DELISTED
Acceleron Pharma Inc.
XLRN
$60.8M 7.62% 1,553,937
VYNE icon
3
VYNE Therapeutics
VYNE
$8.16M
$51.2M 6.42% +1,361,313 New +$51.2M
CRVS icon
4
Corvus Pharmaceuticals
CRVS
$428M
$51M 6.39% 4,420,516 +1,176,470 +36% +$13.6M
COGT icon
5
Cogent Biosciences
COGT
$1.69B
$31.7M 3.97% +665,181 New +$31.7M
AKBA icon
6
Akebia Therapeutics
AKBA
$833M
$29.5M 3.7% 3,100,000 +875,000 +39% +$8.34M
MRUS icon
7
Merus
MRUS
$4.98B
$26.1M 3.28% 1,410,417
GKOS icon
8
Glaukos
GKOS
$5.5B
$17.4M 2.19% 565,165 +408,736 +261% +$12.6M
DERM
9
DELISTED
Dermira, Inc.
DERM
$15.9M 2% 1,993,746 +9,382 +0.5% +$75K
VRNA
10
Verona Pharma
VRNA
$9.16B
$14.8M 1.86% 740,740
NBRV
11
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$14.7M 1.84% 2,924,822
CRSP icon
12
CRISPR Therapeutics
CRSP
$4.71B
$10.2M 1.28% 223,317
KIDS icon
13
OrthoPediatrics
KIDS
$536M
$9.41M 1.18% 624,591 +245,577 +65% +$3.7M
SPNE
14
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$9.33M 1.17% +920,380 New +$9.33M
RARX
15
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$7.78M 0.98% 1,465,838 -565,724 -28% -$3M
WMGIZ
16
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
0
IVTY
17
DELISTED
Invuity, Inc
IVTY
$5.25M 0.66% 1,363,848